Sensus Healthcare, Inc.
A maker of non-invasive medical devices, Sensus Healthcare builds the SRT-100 system that dermatologists use to treat common skin cancers and keloid scars with gentle, low-energy X-rays that spare healthy tissue beneath the skin. Founded around 2010 by Joseph Sardano in Boca Raton, Florida, the company grew out of his long career in medical technology at firms like GE and Siemens. Its name plays on "sensible"—its pitch being a common-sense, surgery-free way to treat skin problems.
Bought 55.0K
Granted 20.0K
Bought 76.2K
Granted 100.0K · Bought 6.0K
Granted 20.0K
Sold 20.0K
Bought 501
Granted 20.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Sardano Joseph CCHIEF EXECUTIVE OFFICER, Director · 3 transactions | +4.7% | 1.22M | — | 55.0K | — |
| McCall William HDirector · 1 transaction | +3457.2% | 355.7Kas of Dec 2024 | 20.0K | — | — |
| Sachetta EricDirector · 6 transactions | — | 211.4K | — | 76.2K | — |
| Sardano MichaelPRESIDENT AND GENERAL COUNSEL, Director · 12 transactions | — | 159.8K | 100.0K | 6.0K | — |
| Petrelli Anthony BenedictDirector · 1 transaction | +43% | 66.5Kas of Dec 2024 | 20.0K | — | — |
| Heinrich JohnDirector · 2 transactions | -25% | 59.9Kas of May 2024 | — | — | 20.0K |
| Rampolla JavierCHIEF FINANCIAL OFFICER · 2 transactions | -7.8% | 40.7Kas of Feb 2025 | — | 501 | — |
| Cornish MeganDirector · 1 transaction | +166.7% | 32.0Kas of Dec 2024 | 20.0K | — | — |
| Martinez MagdalenaCHIEF OPERATING OFFICER · 1 transaction | — | 12.8K | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: +117.7K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.